Kate K. Fieseler
Papers
1
Total Citations
2
H-Index
1
About
Kate K. Fieseler is a rising leader in computational chemistry and structure-based drug discovery, with a focus on fragment-based ligand design and synthetic accessibility. Her most notable contribution is the development of **Syndirella**, a computational platform that enables synthesis-directed fragment elaboration, allowing researchers to explore extensive binding site interactions beyond pre-existing catalog compounds. This work, published in 2025, addresses a critical bottleneck in early-stage drug discovery: maximizing compound diversity and interaction sampling to avoid premature convergence in hit-to-lead optimization. By integrating synthetic feasibility directly into fragment growing and linking strategies, Fieseler’s approach bridges the gap between computational enumeration and practical medicinal chemistry. While her citation record is still building—reflecting the recency of her work—her methodological innovation has already garnered attention for its potential to accelerate the design of high-quality, synthetically tractable leads. Fieseler’s research is particularly impactful for students and researchers seeking to understand how computational tools can be harnessed to expand chemical space exploration while maintaining a tight feedback loop with experimental synthesis. Her work exemplifies the next generation of data-driven, synthesis-aware drug design.
Research Focus
Key Achievements
Top Papers
- 1